Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Bronchogen and Epitalon Interaction: Synergistic | Peptide Database

Compound Profiles Bronchogen AEDL Tetrapeptide | Bronchial Bioregulator Bronchogen works through epigenetic regulation by penetrating cell and nuclear membranes to interact with DNA and modulate gene expression in bronchial tissue. It regulates protein synthes

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Compound Profiles

Bronchogen

AEDL Tetrapeptide | Bronchial Bioregulator

Bronchogen works through epigenetic regulation by penetrating cell and nuclear membranes to interact with DNA and modulate gene expression in bronchial tissue. It regulates protein synthesis in bronchopulmonary cells, supporting maintenance and repair of respiratory epithelium.

Epitalon

Synthetic Pineal Tetrapeptide | Telomerase Activator

Activates telomerase at extremely low concentrations (10⁻¹⁷ to 10⁻¹⁵ M) to maintain telomere length, stimulates melatonin production from the pineal gland, and modulates gene expression through epigenetic mechanisms..

Shared Safety Flags

Frequently Asked Questions

Can I take Bronchogen with Epitalon?

Yes, Bronchogen and Epitalon can generally be taken together. Often combined in comprehensive anti-aging Khavinson protocols.

Is Bronchogen and Epitalon safe together?

Based on documented research, this combination is considered synergistic. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between Bronchogen and Epitalon?

Often combined in comprehensive anti-aging Khavinson protocols. This assessment has 95% confidence and is based on documented research data.

How should I time Bronchogen and Epitalon?

Bronchogen has a half-life of Minutes (short peptide); effects persist via epigenetic changes and Epitalon has a half-life of Not established (short peptide). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

What's the dose range for cognitive enhancement versus being too much?

The cognitive 'sweet spot' is 0.5-2 mg/kg body weight (roughly 35-140 mg for a 70 kg person). Doses above 2 mg/kg often shift from antioxidant to pro-oxidant effects, becoming counterproduc…

Source: peptide-db.com
comparison

Why is TB-500 dosed 2.5x higher in Tri-Heal Max versus standard Wolverine Stack?

Tri-Heal Max emphasizes TB-500's superior cell migration and angiogenesis properties (25mg vs standard 10mg) for more significant tissue damage. The 2.5:1 ratio targets acute injuries, majo…

Source: peptide-db.com
comparison

What's the ideal 5/5 vs 10/3 ratio for Tesa/IPA and when to use each?

5/5 (equal parts) provides balanced GH stimulation suitable for general recovery. The 10/3 (higher tesamorelin) variant emphasizes visceral fat loss and metabolic effects. Choose 5/5 for at…

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

Community Research

Join others researching BAM-15 — share findings, ask questions, and learn from real experiences BAM-15 is a synthetic mitochondrial uncoupler that has emerged as a promising research compound for obesity and metabolic disorders. Unlike traditional uncouplers like DNP which have serious toxicity concerns, BAM-15 demonstrates a superior safety profile while effectively increasing energy expenditure and fat oxidation. Research in mice shows BAM-15 reduces body fat without affecting food intake, lean mass, or body temperature. It is approximately 7-fold more potent than DNP and does not induce the dangerous hyperthermia associated with older uncouplers. Note: BAM-15 is a small molecule compound, not a peptide, but is commonly sold alongside peptide products. BAM-15 targets the inner mitochondrial membrane, enhancing proton permeability and dissipating the proton gradient. This uncouples electron transport from ATP synthesis, forcing mitochondria to increase respiration and burn more substrates (particularly fat) to maintain energy production. BAM-15 activates AMP-activated protein kinase (AMPK) in response to ATP depletion, promoting glucose uptake and fatty acid oxidation. It also activates PGC-1α (peroxisome proliferator-activated receptor gamma coactivator 1-alpha), enhancing mitochondrial biogenesis. Unlike DNP or FCCP, BAM-15 does not depolarize plasma membranes or induce apoptosis at effective concentrations, explaining its improved safety profile.

Source: peptide-db.com ↗

Research Indications

Restores reproductive hormone secretion in functional or congenital cases by stimulating dormant GnRH axis. Triggers oocyte maturation with 45% live birth rate and zero severe OHSS cases; safer than hCG. Restores reproductive hormone pulsatility in women with hypothalamic amenorrhea. Modulates sexual brain processing; increases penile tumescence by 56% vs placebo. Modulates sexual and attraction brain processing; increases self-reported sexiness. Preclinical evidence suggests influence on energy expenditure and activity levels.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Protocols

Oxandrolone is exclusively administered orally as a 17-alpha-alkylated steroid. It is available in tablet form, typically in 2.5 mg, 5 mg, and 10 mg doses. The 17-alpha-methylation provides resistance to first-pass hepatic metabolism, allowing adequate oral bioavailability. Despite the alkylation, oxandrolone is among the least hepatotoxic of oral anabolic steroids, though liver function should still be monitored during use. Medical - Weight Recovery 2.5-20 mg/day Divided into 2-4 doses daily Oral Medical - Burn Recovery 0.1 mg/kg twice daily Twice daily Performance - Male (Conservative) 20-30 mg/day Split into 2 doses (morning and evening) Performance - Male (Standard) 40-50 mg/day Performance - Female 5-20 mg/day Split into 2 doses or taken once daily Performance - Female (Detailed Cycle) Once daily or split into 2 doses

Source: peptide-db.com ↗
Side effects

Common Side Effects

Testosterone suppression (dose-dependent; more suppressive than Ostarine at equivalent doses, occurs in most users by week 4-6) Water retention (non-estrogenic mechanism, typically mild to moderate, contributes to scale weight increase) HDL cholesterol reduction (dose-dependent lipid impact observed in clinical trials) Headaches (most common in the first 1-2 weeks, usually transient) Fatigue or lethargy (related to testosterone suppression, typically becomes noticeable mid-cycle) Reduced libido (related to HPG axis suppression, severity varies by dose and individual)

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →